PAG
MIRM icon

Pinnacle Advisory Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Pinnacle Advisory Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$198K Buy
+10,000
New +$191K 0.01% 243

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Pinnacle Advisory Group's MIRM Position: Q1 2021 in Review

Pinnacle Advisory Group opened a new position in Mirum Pharmaceuticals (MIRM) in Q1 2021: 10,000 shares worth $198K. The stake represents 0.01% of the portfolio and ranks #243 among its holdings.

61 funds tracked by Wall St. Rank hold MIRM as of Q1 2021.

  • Pinnacle Advisory Group held 10,000 shares of Mirum Pharmaceuticals worth $198K as of Q1 2021.
  • Mirum Pharmaceuticals was a new Pinnacle Advisory Group position in Q1 2021.
  • Mirum Pharmaceuticals made up 0.01% of Pinnacle Advisory Group's portfolio in Q1 2021, its #243 holding.
  • 61 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2021.

Based on Pinnacle Advisory Group's 13F filing for Q1 2021, filed 12 May 2021.